Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CBT-I for Psychosis: Guidelines, Preliminary Efficacy, and Functional Outcomes

NCT02535923 is registered in ClinicalTrials.gov with VA Office of Research and Development as lead sponsor.

NCT NCT02535923
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02535923 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CBT-I for Psychosis: Guidelines, Preliminary Efficacy, and Functional Outcomes
Lead sponsor
VA Office of Research and Development
Phase
Not applicable
Overall status
Completed
Start date
March 1, 2018
Completion date
April 20, 2021
Enrollment
47 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

insomnia, psychosis